Impact of SNPs on CpG Islands in the MYC and HRAS oncogenes and in a wide variety of tumor suppressor genes: A multi-cancer approach

References

• Jones PL, Veenstra GJ, Wade PA, Vermaak D, Kass SU, Landsberger N, Strouboulis J, Wolffe AP. Methylated DNA and MeCP2 recruit histone deacetylase to repress transcription. Nat Genet 1998; 19(2):187-91; PMID:9620779; http://dx.doi.org/10.1038/561
   PubMed Web of Science ®Google Scholar
• Voisin S, Almen MS, Zheleznyakova GY, Lundberg L, Zarei S, Castillo S, Eriksson FE, Nilsson EK, Blüher M, Böttcher Y, et al. Many obesity-associated SNPs strongly associate with DNA methylation changes at proximal promoters and enhancers. Genome Med 2015; 7(1):103; PMID:26449484; http://dx.doi.org/10.1186/s13073-015-0225-4.
   PubMed Web of Science ®Google Scholar
• Kato N, Loh M, Takeuchi F, Verweij N, Wang X, Zhang W, Kelly TN, Saleheen D, Lehne B, Mateo Leach I, et al. Trans-ancestry genome-wide association study identifies 12 genetic loci influencing blood pressure and implicates a role for DNA methylation. Nat Genet 2015; 47:1282-93; PMID: 26390057; http://dx.doi.org/10.1038/ng.3405
   PubMed Web of Science ®Google Scholar
• Lemire M, Zaidi SH, Ban M, Ge B, Aissi D, Germain M, Kassam I, Wang M, Zanke BW, Gagnon F, et al. Long-range epigenetic regulation is conferred by genetic variation located at thousands of independent loci. Nat Commun 2015; 6:6326; PMID: 25716334; http://dx.doi.org/10.1038/ncomms7326.
   PubMed Web of Science ®Google Scholar
• Putku M, Kals M, Inno R, Kasela S, Org E, Kozich V, Milani L, Laan M. CDH13 promoter SNPs with pleiotropic effect on cardiometabolic parameters represent methylation QTLs. Hum Genet 2015; 134(3):291-303; PMID:25543204; http://dx.doi.org/10.1007/s00439-014-1521-6
   PubMed Web of Science ®Google Scholar
• Barry KH, Moore LE, Sampson J, Yan L, Meyer A, Oler AJ, Chung CC, Wang Z, Yeager M, Amundadottir L, et al. DNA methylation levels at chromosome 8q24 in peripheral blood are associated with 8q24 cancer susceptibility loci. Cancer Prev Res 2014; 7(12):1282-92; PMID:25315430; http://dx.doi.org/10.1158/1940-6207.CAPR-14-0132
   PubMed Web of Science ®Google Scholar
• Kojima A, Kobayashi T, Ito S, Murasawa A, Nakazono K, Yoshie H. Tumor necrosis factor-alpha gene promoter methylation in Japanese adults with chronic periodontitis and rheumatoid arthritis. J Periodontal Res 2015; PMID:26247485; http://dx.doi.org/10.1111/jre.12314
   PubMed Web of Science ®Google Scholar
• Kalashikam RR, Inagadapa PJ, Thomas AE, Jeyapal S, Giridharan NV, Raghunath M. Leptin gene promoter DNA methylation in WNIN obese mutant rats. Lipids Health Dis 2014; 13:25; PMID: 24495350; http://dx.doi.org/10.1186/1476-511X-13-25
   PubMed Web of Science ®Google Scholar
• Tendl KA, Schulz SM, Mechtler TP, Bohn A, Metz T, Greber-Platzer S, Kasper DC, Herkner KR, Item CB. DNA methylation pattern of CALCA in preterm neonates with bacterial sepsis as a putative epigenetic biomarker. Epigenetics 2013; 8(12):1261-7; PMID:24135723; http://dx.doi.org/10.4161/epi.26645
   PubMed Web of Science ®Google Scholar
• Ford SA, Blanck G. Signal persistence and amplification in cancer development and possible, related opportunities for novel therapies. Biochim Biophys Acta 2014; 1855(1):18-23; PMID:25450826; http://dx.doi.org/10.1016/j.bbcan.2014.11.001
   PubMed Web of Science ®Google Scholar
• Mauro JA, Butler SN, Ramsamooj M, Blanck G. Copy number loss or silencing of apoptosis-effector genes in cancer. Gene 2015; 554(1):50-7; PMID:25307873; http://dx.doi.org/10.1016/j.gene.2014.10.021
   PubMed Web of Science ®Google Scholar
• Szekeres K, Koul R, Mauro J, Lloyd M, Johnson J, Blanck G. An Oct-1-based, feed-forward mechanism of apoptosis inhibited by co-culture with Raji B-cells: towards a model of the cancer cell/B-cell microenvironment. Exp Mol Pathol 2014; 97(3):585-9; PMID:25236570; http://dx.doi.org/10.1016/j.yexmp.2014.09.010
   PubMed Web of Science ®Google Scholar
• Mauro JA, Blanck G. Functionally distinct gene classes as bigger or smaller transcription factor traps: a possible stochastic component to sequential gene expression programs in cancer. Gene 2014; 536(2):398-406; PMID: 24291030; http://dx.doi.org/10.1016/j.gene.2013.11.013
   PubMed Web of Science ®Google Scholar
• Garcia M, Mauro JA, Ramsamooj M, Blanck G. Tumor suppressor genes are larger than apoptosis-effector genes and have more regions of active chromatin: Connection to a stochastic paradigm for sequential gene expression programs. Cell Cycle 2015; 14(15):2494-500; PMID:25945879; http://dx.doi.org/10.1080/15384101.2015.1044179
   PubMed Web of Science ®Google Scholar
• Frangione ML, Lockhart JH, Morton DT, Pava LM, Blanck G. Anticipating designer drug-resistant cancer cells. Drug Discov Today 2015; 20:790-3; PMID:25697478; http://dx.doi.org/10.1016/j.drudis.2015.02.005
   PubMed Web of Science ®Google Scholar
• Senmaru N, Shichinohe T, Takeuchi M, Miyamoto M, Sazawa A, Ogiso Y, Takahashi T, Okushiba S, Takimoto M, Kato H, et al. Suppression of Erk activation and in vivo growth in esophageal cancer cells by the dominant negative Ras mutant, N116Y. Int J Cancer Journal international du cancer 1998; 78(3):366-71; PMID: 9766573; http://dx.doi.org/10.1002/(SICI)1097-0215(19981029)78:3%3c366::AID-IJC18%3e3.0.CO;2-4
   PubMed Web of Science ®Google Scholar
• Gallick GE, Kurzrock R, Kloetzer WS, Arlinghaus RB, Gutterman JU. Expression of p21ras in fresh primary and metastatic human colorectal tumors. Proc Natl Acad Sci U S A 1985; 82(6):1795-9; PMID:3885218; http://dx.doi.org/10.1073/pnas.82.6.1795
   PubMed Web of Science ®Google Scholar
• Ulsh LS, Shih TY. Metabolic turnover of human c-rasH p21 protein of EJ bladder carcinoma and its normal cellular and viral homologs. Mol Cell Biol 1984; 4(8):1647-52;PMID: 6092927; http://dx.doi.org/10.1128/MCB.4.8.1647
   PubMed Web of Science ®Google Scholar
• Johnson TL, Lloyd RV, Burney RE, Thompson NW. Hurthle cell thyroid tumors. An immunohistochemical study. Cancer 1987; 59(1):107-12; PMID:3539304; http://dx.doi.org/10.1002/1097-0142(19870101)59:1%3c107::AID-CNCR2820590123%3e3.0.CO;2-U
   PubMed Web of Science ®Google Scholar
• Yano T, Zissel G, Muller-Qernheim J, Jae Shin S, Satoh H, Ichikawa T. Prostaglandin E2 reinforces the activation of Ras signal pathway in lung adenocarcinoma cells via EP3. FEBS Lett 2002; 518(1–3):154-8; PMID:11997037
   PubMed Web of Science ®Google Scholar
• Huang Y, Boynton RF, Blount PL, Silverstein RJ, Yin J, Tong Y, McDaniel TK, Newkirk C, Resau JH, Sridhara R, et al. Loss of heterozygosity involves multiple tumor suppressor genes in human esophageal cancers. Cancer Res 1992; 52(23):6525-30; PMID:1423299
   PubMed Web of Science ®Google Scholar
• Fearon ER, Cho KR, Nigro JM, Kern SE, Simons JW, Ruppert JM, Hamilton SR, Preisinger AC, Thomas G, Kinzler KW, et al. Identification of a chromosome 18q gene that is altered in colorectal cancers. Science 1990; 247(4938):49-56; PMID:2294591; http://dx.doi.org/10.1126/science.2294591
   PubMed Web of Science ®Google Scholar
• Brewster SF, Gingell JC, Browne S, Brown KW. Loss of heterozygosity on chromosome 18q is associated with muscle-invasive transitional cell carcinoma of the bladder. Br J Cancer 1994; 70(4):697-700; PMID:7917921; http://dx.doi.org/10.1038/bjc.1994.376
   PubMed Web of Science ®Google Scholar
• Kim MS, Shin KH, Baek JH, Cherrick HM, Park NH. HPV-16, tobacco-specific N-nitrosamine, and N-methyl-N'-nitro-N-nitrosoguanidine in oral carcinogenesis. Cancer Research 1993; 53(20):4811-6; PMID: 8402666
   PubMed Web of Science ®Google Scholar